DrugDashboards

Mentholatum

Methyl Salicylate, DL-Menthol · METHYL SALICYLATE 200 mg/g; MENTHOL 60 mg/g · Lotion · Topical · Lydia Co., Ltd.

NDC 72988-0031-01 · 75 g in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Methyl Salicylate, DL-Menthol (Lotion)

LabelerStrengthFirst seenLast seen
Lydia Co., Ltd.METHYL SALICYLATE 200 mg/g; MENTHOL 60 mg/gAug 26, 2026Sep 2, 2026
Lydia Co., Ltd.METHYL SALICYLATE 60 mg/g; MENTHOL 200 mg/gJul 22, 2026Aug 19, 2026
Lydia Co., Ltd.MENTHOL 60 mg/g; METHYL SALICYLATE 200 mg/gJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Mentholatum — NDC 72988-0031-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72988003101.

Free to cite with attribution — see how the data is put together.